Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 10.50
-0.50 (-4.76%)
Jun 13, 2025, 4:35 PM GMT+1
Ondine Biomedical Revenue
In the year 2024, Ondine Biomedical had annual revenue of 2.05M CAD with 70.32% growth. Ondine Biomedical had revenue of 1.19M in the half year ending December 31, 2024, with 216.49% growth.
Revenue
2.05M CAD
Revenue Growth
+70.32%
P/S Ratio
40.93
Revenue / Employee
113.83K CAD
Employees
18
Market Cap
46.56M GBP
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.05M | 846.00K | 70.32% |
| Dec 31, 2023 | 1.20M | 565.00K | 88.56% |
| Dec 31, 2022 | 638.00K | -1.93M | -75.17% |
| Dec 31, 2021 | 2.57M | 778.00K | 43.44% |
| Dec 31, 2020 | 1.79M | 258.16K | 16.84% |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Dec 31, 2007 | Pro | Pro | Pro |
| Dec 31, 2006 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |